PMA P250003S003
- Device
- Embrace™ Hydrogel Embolic System
- Applicant
- Instylla, Inc.
- PMA number
- P250003
- Supplement
- S003
- Product code
- QVG
- Decision date
- 2026-02-04
- Classification
- Cardiovascular
- Generic name
- Embolization Agent, Vascular
- Approval order statement
- a change to the Incoming Citric Acid Inspection Test Method
Current openFDA PMA Record#
- Device
- Embrace™ Hydrogel Embolic System
- Applicant
- Instylla, Inc.
- PMA number
- P250003
- Supplement
- S003
- Product code
- QVG
- Generic name
- Embolization Agent, Vascular
- Decision date
- 2026-02-04
- Decision code
- OK30
- Date received
- 2026-01-06
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Approval order statement
- a change to the Incoming Citric Acid Inspection Test Method